In this episode of MedTech Global Insights, we tackle one of the most significant challenges for MedTech and IVD companies: navigating the complex web of global medical device registration requirements. We explore why a one-size-fits-all approach to market access is doomed to fail and discuss the critical importance of a localized, technology-driven regulatory strategy. We delve into a real-world case study of a promising U.S. startup whose European expansion was delayed by a year due to overlooked regulatory differences between the FDA and EU MDR. This costly mistake highlights the necessity of understanding specific market requirements, from clinical data to technical documentation, and the value of having in-country expertise to avoid common pitfalls. Key Takeaways: - Why is simply translating your technical dossier not enough for global markets? - What are the most common and costly mistakes startups make when trying to expand internationally? - How can you leverage a single registration process to enter multiple markets simultaneously? - What are the specific regulatory hurdles you might face in key markets like Japan or Brazil? - How can AI and data tools prevent critical errors in your submission files? - Why is a local representative more than just a name on a form? - How can you build a regulatory strategy that scales with your company's growth? - What key elements are often missing from technical files when moving from FDA to CE marking? For more information on developing your global regulatory strategy, contact us at [email protected] or visit https://pureglobal.com/.